Comparing high flow nasal cannula to facial masks for chest trauma patients
Official title: Noninvasive Ventilation With High Flow Nasal Cannula Compared With Facial Mask in Patients With Chest Trauma: a Randomized Controlled Study
Run by National Taiwan University Hospital · NCT05828030 · Data updated 2026-11-12
This study is testing if high flow nasal cannulas can help chest trauma patients breathe better and avoid needing a breathing tube compared to regular facial masks.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 99 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 2 sites (Taipei, Taipei and 1 other locations) |
| Status | Recruiting |
| Started | April 26, 2023 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2027 |
| Registry record updated | September 8, 2025 |
| Trial ID | NCT05828030 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients who have experienced chest trauma and exhibit severe hypoxemic respiratory failure within 72 hours of their injury.
✕Probably not a fit
Patients with severe brain injuries or those who are unable to tolerate non-invasive ventilation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of high flow nasal cannula (HFNC) compared to traditional facial masks in patients suffering from severe hypoxemia due to chest trauma. Conducted across three centers, the study will randomize eligible patients who are experiencing respiratory distress and have low arterial oxygen levels despite receiving standard oxygen therapy. The goal is to determine if HFNC can reduce the need for intubation in these patients within the first 72 hours after their injury.
Why it matters
Potential benefit: If successful, this study could provide a less invasive and more effective treatment option for patients with severe hypoxemia due to chest trauma.
How similar studies have gone: While traditional methods for managing hypoxemia in trauma patients have been established, the use of HFNC in this context is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients who have the following condition within 72 hours of chest trauma despite receiving standard nasal cannula oxygen therapy \[≥10 L/min\], are eligible for inclusion. * severe hypoxemic respiratory failure \[Arterial partial pressure of oxygen (PaO2)/fraction of inspired oxygen fraction(FiO2) \<300 mmHg\] * with a respiratory rate \>25 breaths/minute and difficulty breathing, or respiratory distress * PaCO2 of 45 mmHg or higher (if the patient requires emergency surgery with endotracheal intubation and mechanical ventilation, the time of inclusion will be the start of the post-extubation period. (Note: For patients who receive emergency trauma surgery with endotracheal intubation and mechanical ventilation, the time of inclusion assessment will be 72 hours after extubation.) Exclusion Criteria: 1. Patients with a Glasgow Coma Scale less than 8 or severe brain injury. 2. Patients with any contraindications to non-invasive ventilation, including acute gastrointestinal bleeding, upper airway obstruction, or hemodynamic instability. 3. Facial trauma involving skull base fractures, facial bone fractures, or orbital floor fractures. 4. Severe injuries involving the nasal sinuses. 5. Patients with cervical spine injuries. 6. Patients with increased intracranial pressure. 7. Patients with facial, nasal, or airway structural abnormalities or surgery that prevents the use of appropriate nasal cannula. 8. Patients after upper airway surgery. 9. Patients who are unable to clearly express their willingness to sign informed consent.
Where it's running
-
Department of Traumatology, National Taiwain University Hospital
Taipei, Taipei, Taiwan Recruiting -
NTUH Hsin-Chu Branch; NTUH Yun-Lin Branch
Taipei, Taiwan, Taiwan Recruiting
Study contacts
- Principal investigator: Hsien-Chi Liao, MD — department of trauma of National University Hospital
- Study coordinator: Hsien-Chi Liao, MD
- Email: polarisliao@hotmail.com
- Phone: +886-972651611
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How the body responds to exercise with low oxygen in healthy adults
Researchers test how healthy men and women respond to different exercise types while breathing air with varying oxygen levels.
-
How acute low-oxygen levels affect the right side of the heart in asthma
This study tests how short-term exposure to simulated high-altitude oxygen levels affects right heart function in adults with asthma.
-
How short-term low oxygen exposure affects the right side of the heart in healthy adults
We test whether short-term reduced oxygen (simulated 2,500 m and 4,000 m) changes right ventricular function in healthy adults at rest and during light exercise.
-
Right-heart response to short-term low oxygen in people with past HAPE
This trial tests whether brief exposure to simulated high altitude (low oxygen) changes right-heart function in adults who previously had high-altitude pulmonary edema (HAPE).
-
Supraglottic oxygen through a thin nasal tube during deep-sedation bronchoscopy
This trial tests whether inserting a thin, wired endotracheal tube through the nose to deliver oxygen above the vocal cords helps prevent low oxygen levels in adults undergoing deep-sedation fiberoptic bronchoscopy.
-
High-flow nasal oxygen to prevent low oxygen during sedated endoscopy in people with high-risk sleep apnea
This will test whether using high‑flow nasal oxygen instead of a regular nasal cannula prevents low oxygen levels during propofol‑sedated gastroscopy or colonoscopy in adults with high‑risk obstructive sleep apnea (STOP‑Bang ≥5).
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.